C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

Ridker, Paul M, Paynter, Nina P., Rifai, Nader, Gaziano, J. Michael, Cook, Nancy R.·2008·Circulation
DOI 10.1161/circulationaha.108.814251

Cited by (840)

Items 601–700 of 840

  1. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and
    Elaboration G. M. Moons, Douglas G. Altman, Johannes B. Reitsma, Petra Macaskill, Ewout Willem Steyerberg, Andrew Julian Vickers, David F. Ransohoff, Professor Gary S. Collins · 2015
  2. Circulating early biomarkers of atherogenesis in participants of the Longitudinal Study of Adult Health (ELSA-Brasil) without diabetes or cardiovascular disease
    Bianca de Almeida-Pititto, Fernando Flexa Ribeiro‐Filho, Sandhi Maria Barreto, Bruce Bartholow Duncan, María Inês Schmidt, Paulo A. Lotufo, Isabela M. Benseñor, Sandra Roberta G. Ferreira · 2016 · Archives of Endocrinology and Metabolism
  3. Clinical perspective: Have the results of recent clinical trials of lipid-lowering therapies influenced the way we should practice? A Latin American perspective of current issues in clinical lipidology
    Raul Dias Santos, Alberto J. Lorenzatti, Carlos Fernandez Barros, Edgardo Escobar · 2011 · Journal of clinical lipidology
  4. Protective molecules and their cognate antibodies: new players in autoimmunity
    Margherita Zen, Nicola Bassi, Carla Campana, Silvano Bettio, Elena Tarricone, Linda Nalotto, Anna Ghirardello, Andrea Doria · 2010 · Autoimmunity Highlights
  5. Development and Evaluation of an Ecological Display for the Detection, Evaluation, and Treatment of Cardiovascular Risk
    Timothy R. McEwen · 2012 · CORE Scholar (Wright State University)
  6. Online Adaptive Coronary Heart Disease Risk Prediction Model
    Jostinah Lam, Eko Supriyanto, Faris Yahya, Muhammad Haikal Satria, Suhaini Kadiman, Aizai Azan, Amiliana Mardiani Soesanto · 2017 · MATEC Web of Conferences
  7. Gender differences in acute coronary syndromes: focus on the women with ACS without an obstructing culprit lesion
    Jane S. Titterington, Olivia Y. Hung, Anita P. Saraf, NANETTE KASS WENGER · 2018 · Expert Review of Cardiovascular Therapy
  8. Utility of Advanced Lipoprotein Testing in Clinical Practice
    Kenneth R. Feingold, Carl Grünfeld · 2016 · Europe PMC (PubMed Central)
  9. Article Commentary: Screening for cardiovascular disease using age alone: reflections on a paper Peer-Reviewed as both ‘radical’ and ‘unsurprising’
    Richard W. Smith · 2011 · Journal of Medical Screening
  10. Improving risk prediction is not easy
    Yvo Michiel Smulders · 2018 · European Journal of Preventive Cardiology
  11. Inherited risk of coronary artery disease: redefining care with imaging and genetics
    Nick S.R. Lan, Girish Dwivedi, Graham S. Hillis, Derek P. Chew, Bu Beng Yeap, Gemma A. Figtree, Amit V. Khera, Gerald Francis Watts, Abdul Rahman Ihdayhid · 2026 · Nature Reviews Cardiology
  12. Incremental Prognostic Value of Exercise Stress Testing in Primary Prevention
    Alaa Alashi, Haris Riaz, Richard S. Lang, Raul John Seballos, Steven Elliot Feinleib, Roxanne B. Sukol, Leslie Cho, Paul C Cremer, Wael A. Jaber, Brian P. Griffin et al. · 2019 · The American Journal of Cardiology
  13. Machine Learning Models for Predicting Stroke Mortality in Malaysia: An Application and Comparative Analysis
    Che Muhammad Nur Hidayat Che Nawi, Suhaily Mohd Hairon, Wan Nur Nafisah Wan Yahya, Wan Asyraf Wan Zaidi, Kamarul Imran Musa · 2023 · Cureus
  14. Nuevos marcadores de riesgo cardiovascular. ¿Pueden influir en la clasificación del riesgo cardiovascular?
    Julio Antonio Carbayo Herencia · 2011 · Clínica e Investigación en Arteriosclerosis
  15. A novel approach to identify optimal metabotypes of elongase and desaturase activities in prevention of acute coronary syndrome
    Nathan Tintle, John W. I. Newman, Gregory C. Shearer · 2015 · Metabolomics
  16. Hypertension: From Epidemiology to Therapeutics
    Manuel Velasco, Zafar H. Israili · 2012 · International Journal of Hypertension
  17. Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatin
    Shirya Rashid · 2009 · World Journal of Cardiology
  18. Aterosclerosis: biomarcadores plasmáticos emergentes
    Silvia Fabiana Benozzi, Raúl Ignacio Coniglio · 2010 · Redalyc (Universidad Autónoma del Estado de México)
  19. Guidelines American College of Cardiology/American Heart Association Task Force on Practice 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the
    Jennifer G. Robinson, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith, Paul D. Sorlie, Philip Greenland, Daniel T. Lackland, Daniel A Levy, Christopher J. O’Donnell, David Calvin Goff et al. · 2013
  20. The Prognostic Value of Family History for the Estimation of Cardiovascular Mortality Risk in Men: Results from a Long-Term Cohort Study in Lithuania
    Abdonas Tamošiūnas, Ričardas Radišauskas, Jūratė Klumbienė, Gailutė Bernotienė, Janina Petkevičienė, Dalia Lukšienė, Dalia Virvičiūtė, Vilija A. Malinauskiene, Olga Vikhireva, Vilius Jonas Grabauskas · 2015 · PLoS ONE
  21. Tomography, and Society for Cardiovascular Magnetic Resonance Angiography and Interventions, Society of Cardiovascular Computed Atherosclerosis Imaging and Prevention, Society for Cardiovascular Echocardiography, American Society of Nuclear Cardiology, Society of Developed in Collaboration With the American Society of Guidelines of Cardiology Foundation/American Heart Association Task Force on Practice Asymptomatic Adults: Executive Summary: A Report of the American College 2010 ACCF/AHA …
    Jo Taylor, William S. Weintraub, NANETTE KASS WENGER, Frederick G. Kushner, Michael S. Lauer, Leslee J. Shaw, Sidney C. Smith, Zahi Adel Fayad, Elyse Foster, Mark Andrew Hlatky et al. · 2011
  22. Family History and Health Risk Assessment
    Wendy S. Rubinstein · 2012 · Elsevier eBooks
  23. DEVELOPMENT AND CASE-CONTROL VALIDATION OF THE CANADIAN MEN’S HEALTH FOUNDATION’S SELF RISK-ASSESSMENT TOOL: “YOU CHECK”
    Farshad Pourmalek, S. Larry Goldenberg, Kendall Ho, Sean Skeldon, David M. Patrick · 2017 · Journal of Men s Health
  24. Modelos de predicción de riesgo cardiovascular
    José Raúl Moreno Gómez, Laura Nataly Higuita Duque, Juan José Castro-Palacio · 2017 · Medicina UPB
  25. Atherosclerotic Plaque Imaging
    Begoña Lavín, Pierre Gebhardt, Alkystis Phinikaridou, René Michael Botnar · 2017 · Springer eBooks
  26. Use of Coronary Artery Calcium Quantification and Distribution for Coronary Vascular Disease Risk Reclassification in a Primary Prevention Setting
    Adel Hajj Ali, Michael Nakhla, Leslie Cho, Raul John Seballos, Richard S. Lang, Steven Elliot Feinleib, Scott D. Flamm, Paul Schoenhagen, Tom Wang, Milind Y. Desai · 2023 · The American Journal of Cardiology
  27. Physical activity and cardiometabolic risk factors in sprint and jump-trained masters athletes, young athletes and non-physically active men
    Jörn Rittweger, Wolfram Sies, Miriam Capri, Dominik Hans Pesta · 2024 · Translational Exercise Biomedicine
  28. Cost-Effective Prevention of Coronary Heart Disease
    D. Ashen · 2010 · The Journal for Nurse Practitioners
  29. MARCADORES CARDIACOS Y RIESGO CARDIOVASCULAR
    David Doron R., Marcelo Muñoz C. · 2015 · Revista Médica Clínica Las Condes
  30. Treating antiretroviral-induced dyslipidemia in HIV-infected adults
    Kristine Anne Scordo · 2010 · The Nurse Practitioner
  31. Effects of C-Reactive Protein on CC Chemokine Receptor 2-Mediated Chemotaxis of Monocytes
    Shu Meng, Lin Zhang, Леи Жао, Yi-ru Fang, Tetsuya Fujimoto, Shun-ichiro Hirano, Hiroshi Inoue, Kenji Uchihashi, Yasuo Nishikawa, Yafei Wu · 2011 · DNA and Cell Biology
  32. Genomic profiling by machine learning
    Zhiping Zhang, Honghuang Lin · 2011 · IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW)
  33. The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk
    Maaike Weijmans, Yolanda van der Graaf, Gert Jan de Borst, Folkert Wouter Asselbergs, Maarten Jan Cramer, Ale Algra, Frank L.J. Visseren · 2015 · American Heart Journal
  34. Circulating Vascular Endothelial Growth Factor-1 in Cardiovascular Disease
    Alexander Е. Berezin · 2015 · Springer eBooks
  35. Predicted burden could replace predicted risk in preventive strategies for cardiovascular disease
    Ghizelda R. Lagerweij, G. Ardine de Wit, Karel G.M. Moons, W. M. Monique Verschuren, Jolanda M.A. Boer, Hendrik Koffijberg · 2017 · Journal of Clinical Epidemiology
  36. Comparison between Policaptil Gel Retard and Metformin by Testing of Temporal Changes in Patients with Metabolic Syndrome and Type 2 Diabetes
    Giuseppina Guarino, Felice Strollo, Teresa Della Corte, Ersilia Satta, Carmine Romano, Carmelo Alfarone, Gerardo Corigliano, Marco Corigliano, Giuseppe Cozzolino, Clementina Brancario et al. · 2022 · Diabetology
  37. How to Identify the Asymptomatic High-Risk Patient?
    Joanne Désirée Schuijf, Stephan S. Achenbach, William A. Zoghbi, Eric H. Boersma, Paolo Raggi, Michael A. Weber, Eike C. Nagel, Jagat Narula, Frans J. Th. Wackers, Don Poldermans et al. · 2009 · Current Problems in Cardiology
  38. Screening for Atherosclerotic Cardiovascular Disease in Asymptomatic Individuals
    Erin D. Michos, Michael Joseph Blaha, Seth Shay Martin, Roger Scott Blumenthal · 2017 · Elsevier eBooks
  39. Biomarkers of Cardiac Injury
    Anthony S. McLean, Stephen Huang · 2010 · Biomarkers
  40. Regarding REGARDS: Does Inflammation Explain Racial and Regional Differences in Cardiovascular Disease Risk?
    Nancy R. Cook, Michelle Asha Albert · 2009 · Clinical Chemistry
  41. Intersecting Vectors of Basic Science Research and Clinical Medicine: LOX-1?
    Jonthan Brown, Shriram Nallamshetty, Jorge Plutzky · 2010 · Clinical Chemistry
  42. Carotid Plaque Assessment
    Tatjana Rundek, Maya Salameh · 2010 · Journal of the American College of Cardiology
  43. Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward
    Evangelia G. Sigala, Demosthenes B. Panagiotakos · 2024 · Current Cardiology Reviews
  44. AI in Personalized Medicines: Opportunities and Challenges
    Ayushi Gupta, Anurag Sharma, Neelkanth Mani Pujari, Akash Ved · 2025 · Journal of Drug Discovery and Health Sciences
  45. Anitschkow Award Lecture 2025: Inflammation screening and inflammation inhibition for atherosclerotic disease
    Paul M. Ridker · 2026 · Atherosclerosis
  46. Comparison of SCORE and Reynolds cardiovascular risk assessments in a cohort without cardiovascular disease
    Csaba Móczár · 2013 · Orvosi Hetilap
  47. The accuracy of fibrinogen and hs-crp as a biomarker in acute coronary syndrome (ACS)
    Djanggan Sargowo · 2015 · Indonesian Journal of Cardiology
  48. Proteína C reactiva, aspectos cardiovasculares de una proteína de fase aguda: una actualización para el médico
    Arturo Sáenz-San Martín, Pablo Méndez-Ocampo, Iván Gutiérrez-Moctezuma, Luis Manuel Amezcua-Guerra · 2024 · Archivos de cardiología de México
  49. Cardiovascular Risk Assessment Scores: A Narrative Review
    Dhriti Jain, Sourya Acharya, Samarth Shukla, Nikhil Kaushik · 2024 · Journal of the Practice of Cardiovascular Sciences
  50. Clinical Use of Serum Biomarkers in the Prediction of Cardiovascular Risk
    Mohammad Madjid, James T. Willerson · 2015 · Cardiovascular medicine
  51. Total 10-year risk of death from cardiovascular disease in 25—64 year-old men in Tyumen
    Georgiy S Pushkarev, Кузнецов Вадим Анатольевич, Акимова Екатерина Викторовна · 2020 · Russian Journal of Preventive Medicine
  52. Atherosclerosis, Vulnerable Plaques, and Acute Coronary Syndromes
    Jacob Fog Bentzon, Erling Falk · 2012 · Elsevier eBooks
  53. Reynolds Risk Score as a Risk Assessment Tool for Cardiovascular Disease After 10 Years: Its Strong Relationship With Blood Pressure
    Tomoyuki Kawada · 2012 · Journal of Clinical Hypertension
  54. Translation of Family Health History Questions on Cardiovascular Disease and Type 2 Diabetes with Implications for Latina Health and Nursing Practice
    Gia Mudd‐Martin, Maria C. Martinez · 2011 · Nursing Clinics of North America
  55. Assessment of Cardiovascular Risk – The Impact and Future of Non-traditional Cardiovascular Risk Markers
    Michael Hecht Olsen · 2010 · European Cardiology Review
  56. Predicting Long-Term Cardiovascular Risk Using the Mayo Clinic Cardiovascular Risk Score in a Referral Population
    Abhijeet Dhoble, Brian D. Lahr, Thomas G. Allison, Kent R. Bailey, Randal J. Thomas, Francisco Alejandro López-Jiménez, Iftikhar J. Kullo, Bhanu P Gupta, Stephen Louis Kopecky · 2014 · The American Journal of Cardiology
  57. Does Self-Reported Physical Activity Underestimate the Importance of Activity in Cardiovascular Disease Prevention?
    Steve Anton, Todd Matthew Manini · 2010 · Current Cardiovascular Risk Reports
  58. A Suggested Paradigm for Coronary Risk Screening in Asymptomatic Persons—Assessment of Total Coronary Atheromatous Burden
    Constantine N. Aroney · 2012 · Heart Lung and Circulation
  59. Targeting treatment using calculated cardiovascular disease risk: Effective? A shot in the dark? Or is it time to change the paradigm?
    Tim Reynolds · 2009 · International Journal of Clinical Practice
  60. Putting protection first: vascular risk assessment in atypical populations
    Anthony S. Wierzbicki, Barry S. Peters · 2010 · International Journal of Clinical Practice
  61. Is the association between optimistic cardiovascular risk perceptions and lower rates of cardiovascular disease mortality explained by biomarkers of systemic inflammation or endothelial function? A case-cohort study
    Robert E. Gramling, Kathi L. Heffner, William M. P. Klein, Laura E. Zajac, Mary B. Roberts, Charles B. Eaton · 2010 · BioPsychoSocial Medicine
  62. Cardiovascular risk assessment
    Dirk Jacobus Blom · 2011 · South African Family Practice
  63. Predicted value of serial measurements of circulat- ing vascular endothelial growth factor-1 in arterial hypertension patients after acute ischaemic stroke
    Alexander Е. Berezin, O. O. Lisova · 2014
  64. [Possibilities and limitations of neurosurgery].
    F Pampus · 1965 · PubMed
  65. An Investigation of the Effects of Aerobic Exercise on Serum Brain Natriuretic Peptide and C-Reactive Protein in women with Cardiovascular Diseases
    Najmeh Sheykhiyan, Eskandar Rahami, Mohammad Ali Ostovan · 2015 · DOAJ (DOAJ: Directory of Open Access Journals)
  66. Combination of Fibrinogen and High-sensitivity C-reactive Protein Measurements is Potential in Identification of Acute Coronary Syndrome
    Djanggan Sargowo, Ferry Sandra · 2015 · The Indonesian Biomedical Journal
  67. Novel Biomarkers and the Assessment of Cardiovascular Risk
    Vijay Nambi, Ariel Brautbar, Christie Mitchell Ballantyne · 2011 · Elsevier eBooks
  68. Cardiovascular Risk Assessment: From Global Risk Scoring to Risk Enhancing Factors
    Rina Mauricio, Amit Khera · 2020 · Contemporary cardiology
  69. Automated Cardiovascular Disease Prediction Models: A Comparative Analysis
    Taffazul H. Choudhury, Bismita Choudhury · 2023 · EAI Endorsed Transactions on Pervasive Health and Technology
  70. Re-evaluating the mythical divide between traditional and novel cardiovascular risk factors in rheumatoid arthritis
    Eirik Ikdahl, Mats Julius Stensrud · 2024 · RMD Open
  71. Biomarkers and Imaging Modalities to Detect Subclinical Atherosclerotic Cardiovascular Disease
    Catherine J. McNeal, Philip D. Houck, Nguyen N. Nguyen, James A. Murchison, Harry Chiang · 2024 · Contemporary cardiology
  72. Multiple biomarker assessment in primary prevention of cardiovascular disease
    Lori B. Daniels · 2009 · Current Cardiovascular Risk Reports
  73. Microsimulation model to predict incremental value of biomarkers added to prognostic models
    Karol Mateusz Pencina, Ralph B. D’Agostino, Ramachandran Srini Vasan, Michael J. Pencina · 2018 · Journal of the American Medical Informatics Association
  74. Relationship between plasma high-sensitivity C-reactive protein and traditional cardiovascular risk factors among active-duty military personnel in the Republic of Serbia
    Nenad Ratković, Milena S. Pandrc, Vitomir Perić, Maja Stojanović, Nemanja Rančić · 2021 · Vojnosanitetski pregled
  75. The Case for C-Reactive Protein as a Risk Marker for Coronary Heart Disease
    Nancy R. Cook · 2010 · Annals of Internal Medicine
  76. The SHAPE Paradigm
    Prediman K. Shah · 2010 · Circulation Cardiovascular Quality and Outcomes
  77. Influência do tratamento periodontal sobre os marcadores de risco para aterosclerose em pacientes com periodontite crônica.
    Andrea Moreira Monteiro · 2010
  78. Transition nutritionnelle et double fardeau de la malnutrition chez des adultes de Ouagadougou au Burkina Faso (Afrique de l’Ouest)
    Augustin Nawidimbasba Zeba · 2012
  79. Use of polygenic risk scores and other molecular markers to enhance cardiovascular risk prediction: prospective cohort study and modelling analysis
    Luanluan Sun, Lisa A M Pennells, Stephen K. Kaptoge, Christopher P. Nelson, Gad Abraham, Matthew Arnold, Steven Bell, Thomas R Bolton, Stephen Burgess, Frank Dudbridge et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Putting It All Together
    Christopher B. Fordyce, Pamela S. Douglas · 2017 · Elsevier eBooks
  81. Composite Risk Scores
    Ruth E. Brown, Jennifer Linchee Kuk · 2016 · Springer eBooks
  82. Propensity score-based adjustment for covariate effects on classification accuracy of bio-marker using ROC curve
    Muntaha Mushfiquee, Mohammad Shafiqur Rahman · 2022 · Biostatistics & Epidemiology
  83. Design and Development of Halyos: A Patient-Facing Visual EHR Interface for Longitudinal Risk Awareness
    Samson J. Mataraso, Vimig Socrates, Fritz Lekschas, Nils Gehlenborg · 2022 · ACI Open
  84. Soluble urokinase plasminogen activator receptor biomarker is not a predictor of mortality in high-risk hip fracture patients
    Konstantinos Ioannis Avgerinos, Spyridon Katsanos, Pavlos Altsitzioglou, Alexandros Zikopoulos, Anastasios G Roustemis, Orestis Konstantas, Ioannis Zafeiris, Fotini Soucacos, Dimitrios Serenidis, Dimitrios Stylianos Mastrokalos et al. · 2025 · European Journal of Orthopaedic Surgery & Traumatology
  85. Dietary Patterns for Cardiometabolic Risk Reduction: Moving from Evidence to Implementation
    Laura Chiavaroli, Andrea J. Glenn, Meaghan E Kavanagh, Cyril W.C. Kendall, John L. Sievenpiper · 2025 · Springer eBooks
  86. Mapping and evaluation of global and country-specific cardiovascular disease risk prediction models
    Samina Akhtar, Zainab Samad, Gerald S. Bloomfield, Salim S. Virani, Aysha Almas · 2026 · Future Cardiology
  87. An Anti-Inflammatory Approach in the Therapeutic Choices for the Prevention of Atherosclerotic Events
    Aldo Pende, Andrea Denegri · 2012 · InTech eBooks
  88. [Evidence-based cardiology: practical applications from epidemiology. IV Cardiovascular risk prediction].
    Juan Pablo Rodríguez-Escudero, Francisco López-Jiménez, Jorge F. Trejo-Gutiérrez · 2012 · PubMed
  89. Biomarkers for Prediction of Cardiovascular Events—Reply
    Olle Melander · 2009 · JAMA
  90. Does the Framingham Risk Score Predict Risk in Women as Well as It Does in Men?
    Lewis H. Kuller · 2010 · Current Cardiovascular Risk Reports
  91. Inflammation: The Link Between Obesity and Cardiovascular Risk
    Paolo Calabrò, Enrica Golia, Lucia Riegler, Giuseppe Limongelli, Paolo Golino, Maria Giovanna Russo, Raffaele Calabrò · 2010 · Current Cardiovascular Risk Reports
  92. Usefulness of Reynolds Risk Score in men with stable angina
    Inga Piętka, Agata Sakowicz, Tadeusz Pietrucha, Anna Cichocka‐Radwan, Małgorzata Lelonek · 2013 · Open Medicine
  93. C-reactive protein as an inflammatory marker of acute infections outside intensive care settings: case report and evidence-based literature review
    Alcino Pires Gama, Itamar S Santos, Rodrigo Díaz Olmos, Lúcia Mendes de Oliveira Pinto, Isabela M. Benseñor, Paulo A. Lotufo · 2011 · Autopsy and Case Reports
  94. Northern Light: A Commentary on the 2009 Canadian Guidelines for the Diagnosis and Treatment of Dyslipidemia and Prevention of Cardiovascular Disease in Adults
    Ernst J. Schaefer · 2010 · Clinical Chemistry
  95. Genetics and Cardiovascular Risk Prediction: A Step Toward Personalized Medicine?
    Roberto Elosúa, Gavin Lucas, Carla Lluís-Ganella · 2013 · Current Cardiovascular Risk Reports
  96. A comparison of stroke and coronary risks in Chinese and American
    Mengya Li, Zhenlu Zhang, Youping Chen · 2015 · International Journal of Cardiology
  97. Cardiovascular Health vs Cardiovascular Risk A 2011 Update: Cardiovascular Risk Stratification, the Basis to Reach Therapeutic Goals
    Enrique C. Morales Villegas · 2011 · Current Hypertension Reviews
  98. Carotid ultrasonography in the assessment of cardiovascular risk
    , · 2015 · Cardiovascular Medicine
  99. Risk Prediction in Cardiovascular Medicine Cardiovascular Risk Prediction Basic Concepts, Current Status, and Future Directions
    Donald M. Lloyd‐Jones · 2016
  100. Asymptomatic Adults: Executive Summary 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in
    Allen J. Taylor, William S. Weintraub, NANETTE KASS WENGER, Frederick G. Kushner, Michael S. Lauer, Leslee J. Shaw · 2010